Terms: = Leukemia AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
747 results:
1. Self-Stimulated Photodynamic Nanoreactor in Combination with cxcr4 Antagonists for Antileukemia Therapy.
Zhang Y; Chen L; Fu T; Xu A; Li K; Hao K; Lyu J; Wang Z; Kong F
ACS Appl Mater Interfaces; 2024 May; 16(17):21610-21622. PubMed ID: 38647446
[TBL] [Abstract] [Full Text] [Related]
2. cxcr4 overexpression in chronic lymphocytic leukemia associates with poorer prognosis: A prospective, single-center, observational study.
Xue X; Wen Z; Zhang X; Yang Y; Li Y; Liao R; Zheng Q; Fu Y; Liu Y; Liao H
Genes Immun; 2024 Apr; 25(2):117-123. PubMed ID: 38366101
[TBL] [Abstract] [Full Text] [Related]
3. Thymic-Epithelial-Cell-Dependent Microenvironment Influences Proliferation and Apoptosis of Leukemic Cells.
Patel SK; Zhdanovskaya N; Sergio I; Cardinale A; Rosichini M; Varricchio C; Pace E; Capalbo C; Locatelli F; Macone A; Velardi E; Palermo R; Felli MP
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338689
[TBL] [Abstract] [Full Text] [Related]
4. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
5. C-X-C motif chemokine receptor 4 inhibition promotes the effect of plantamajoside in hepatocellular carcinoma.
Sun J; Liu W; Fu H; Li Y; Huang J; Wang Y; Zhu L
Arab J Gastroenterol; 2024 Feb; 25(1):28-36. PubMed ID: 38220479
[TBL] [Abstract] [Full Text] [Related]
6. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.
Sims NA; Lévesque JP
Curr Osteoporos Rep; 2024 Feb; 22(1):80-95. PubMed ID: 38198032
[TBL] [Abstract] [Full Text] [Related]
7. Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow.
Sanz-Ortega L; Andersson A; Carlsten M
Leukemia; 2024 Mar; 38(3):579-589. PubMed ID: 38182818
[TBL] [Abstract] [Full Text] [Related]
8. Indolent B-cell lymphoma with t(14;19) investigated from a molecular perspective.
Karrs JX; Sathyanarayana SH; Xu X; Green DC; Kahn WA; Loo EY; Kaur P
J Hematop; 2023 Dec; 16(4):217-221. PubMed ID: 38175432
[TBL] [Abstract] [Full Text] [Related]
9. Motixafortide: First Approval.
Hoy SM
Drugs; 2023 Nov; 83(17):1635-1643. PubMed ID: 37996648
[TBL] [Abstract] [Full Text] [Related]
10. The promise of novel treatments for severe chronic neutropenia.
Dale DC; Bolyard AA; Makaryan V
Expert Rev Hematol; 2023; 16(12):1025-1033. PubMed ID: 37978893
[TBL] [Abstract] [Full Text] [Related]
11. Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia.
Aoki K; Hyuga M; Tarumoto Y; Nishibuchi G; Ueda A; Ochi Y; Sugino S; Mikami T; Kobushi H; Kato I; Akahane K; Inukai T; Takaori-Kondo A; Takita J; Ogawa S; Yusa K
Blood; 2024 Feb; 143(7):604-618. PubMed ID: 37922452
[TBL] [Abstract] [Full Text] [Related]
12. BM-MSCs display altered gene expression profiles in B-cell acute lymphoblastic leukemia niches and exert pro-proliferative effects via overexpression of IFI6.
Pan C; Hu T; Liu P; Ma D; Cao S; Shang Q; Zhang L; Chen Q; Fang Q; Wang J
J Transl Med; 2023 Sep; 21(1):593. PubMed ID: 37670388
[TBL] [Abstract] [Full Text] [Related]
13. Research Progress of cxcr4-Targeting Radioligands for Oncologic Imaging.
Wang Y; Gao F
Korean J Radiol; 2023 Sep; 24(9):871-889. PubMed ID: 37634642
[TBL] [Abstract] [Full Text] [Related]
14. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal.
Li Y; Xue M; Deng X; Dong L; Nguyen LXT; Ren L; Han L; Li C; Xue J; Zhao Z; Li W; Qing Y; Shen C; Tan B; Chen Z; Leung K; Wang K; Swaminathan S; Li L; Wunderlich M; Mulloy JC; Li X; Chen H; Zhang B; Horne D; Rosen ST; Marcucci G; Xu M; Li Z; Wei M; Tian J; Shen B; Su R; Chen J
Cell Stem Cell; 2023 Aug; 30(8):1072-1090.e10. PubMed ID: 37541212
[TBL] [Abstract] [Full Text] [Related]
15. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
Au TY; Arudkumar J; Assavarittirong C; Benjamin S
Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
[TBL] [Abstract] [Full Text] [Related]
16. CXCL12-cxcr4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications.
Yang Y; Li J; Lei W; Wang H; Ni Y; Liu Y; Yan H; Tian Y; Wang Z; Yang Z; Yang S; Yang Y; Wang Q
Int J Biol Sci; 2023; 19(11):3341-3359. PubMed ID: 37497001
[TBL] [Abstract] [Full Text] [Related]
17. The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways.
Yaslianifard S; Movahedi M; Yaslianifard S; Mozhgani SH
BMC Res Notes; 2023 Jul; 16(1):147. PubMed ID: 37461070
[TBL] [Abstract] [Full Text] [Related]
18. Functional consequences of inhibition of Bruton's tyrosine kinase by ibrutinib in chronic lymphocytic leukemia.
Chen SS; Chiorazzi N
Hematol Oncol; 2023 Jun; 41 Suppl 1():119-128. PubMed ID: 37294973
[TBL] [Abstract] [Full Text] [Related]
19. Theranostics in Hematooncology.
Buck AK; Serfling SE; Kraus S; Samnick S; Dreher N; Higuchi T; Rasche L; Einsele H; Werner RA
J Nucl Med; 2023 Jul; 64(7):1009-1016. PubMed ID: 37290799
[TBL] [Abstract] [Full Text] [Related]
20. Targeting cxcr4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Liu S; Xie SM; Liu W; Gagea M; Hanker AB; Nguyen N; Singareeka Raghavendra A; Yang-Kolodji G; Chu F; Neelapu SS; Marchese A; Hanash S; Zimmermann J; Arteaga CL; Tripathy D
Breast Cancer Res; 2023 Jun; 25(1):62. PubMed ID: 37280713
[TBL] [Abstract] [Full Text] [Related]
[Next]
